285 related articles for article (PubMed ID: 29857001)
1. Readthrough of ACTN3 577X nonsense mutation produces full-length α-actinin-3 protein.
Harada N; Hatakeyama A; Okuyama M; Miyatake Y; Nakagawa T; Kuroda M; Masumoto S; Tsutsumi R; Nakaya Y; Sakaue H
Biochem Biophys Res Commun; 2018 Jul; 502(3):422-428. PubMed ID: 29857001
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of Actn2 and Actn3 expression during unfolded protein response in C2C12 myotubes.
Harada N; Gotoda Y; Hatakeyama A; Nakagawa T; Miyatake Y; Kuroda M; Masumoto S; Tsutsumi R; Nakaya Y; Sakaue H
J Muscle Res Cell Motil; 2020 Sep; 41(2-3):199-209. PubMed ID: 32451822
[TBL] [Abstract][Full Text] [Related]
3. No association of the ACTN3 gene R577X polymorphism with endurance performance in Ironman Triathlons.
Saunders CJ; September AV; Xenophontos SL; Cariolou MA; Anastassiades LC; Noakes TD; Collins M
Ann Hum Genet; 2007 Nov; 71(Pt 6):777-81. PubMed ID: 17627799
[TBL] [Abstract][Full Text] [Related]
4. Why is alpha-actinin-3 deficiency so common in the general population? The evolution of athletic performance.
North K
Twin Res Hum Genet; 2008 Aug; 11(4):384-94. PubMed ID: 18637739
[TBL] [Abstract][Full Text] [Related]
5. Genotype Distribution of the
Abián-Vicén J; Abián P; Bravo-Sánchez A; Piñas-Bonilla I; Lara B; Del Coso J
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672791
[TBL] [Abstract][Full Text] [Related]
6. Strength, power, fiber types, and mRNA expression in trained men and women with different ACTN3 R577X genotypes.
Norman B; Esbjörnsson M; Rundqvist H; Osterlund T; von Walden F; Tesch PA
J Appl Physiol (1985); 2009 Mar; 106(3):959-65. PubMed ID: 19150855
[TBL] [Abstract][Full Text] [Related]
7. The aminoglycoside geneticin permits translational readthrough of the CTNS W138X nonsense mutation in fibroblasts from patients with nephropathic cystinosis.
Brasell EJ; Chu L; El Kares R; Seo JH; Loesch R; Iglesias DM; Goodyer P
Pediatr Nephrol; 2019 May; 34(5):873-881. PubMed ID: 30413946
[TBL] [Abstract][Full Text] [Related]
8. ACTN3 R577X genotypes associate with Class II and deepbite malocclusions.
Zebrick B; Teeramongkolgul T; Nicot R; Horton MJ; Raoul G; Ferri J; Vieira AR; Sciote JJ
Am J Orthod Dentofacial Orthop; 2014 Nov; 146(5):603-11. PubMed ID: 25439211
[TBL] [Abstract][Full Text] [Related]
9. Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells.
Bidou L; Bugaud O; Belakhov V; Baasov T; Namy O
RNA Biol; 2017 Mar; 14(3):378-388. PubMed ID: 28145797
[TBL] [Abstract][Full Text] [Related]
10. alpha-actinin-3 and performance.
Yang N; Garton F; North K
Med Sport Sci; 2009; 54():88-101. PubMed ID: 19696509
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of the actin-binding proteins, alpha-actinin-2 and -3, in different species: implications for the evolution of functional redundancy.
Mills M; Yang N; Weinberger R; Vander Woude DL; Beggs AH; Easteal S; North K
Hum Mol Genet; 2001 Jun; 10(13):1335-46. PubMed ID: 11440986
[TBL] [Abstract][Full Text] [Related]
12. Is evolutionary loss our gain? The role of ACTN3 p.Arg577Ter (R577X) genotype in athletic performance, ageing, and disease.
Houweling PJ; Papadimitriou ID; Seto JT; Pérez LM; Coso JD; North KN; Lucia A; Eynon N
Hum Mutat; 2018 Dec; 39(12):1774-1787. PubMed ID: 30281865
[TBL] [Abstract][Full Text] [Related]
13. The ACTN3 R577X polymorphism is associated with inflammatory myopathies in a Mexican population.
Sandoval-García F; Petri MH; Saavedra MA; Cruz-Reyes CV; Jara-Quezada LJ; Dávalos-Rodríguez IP; Salazar-Páramo M; Gámez-Nava JI; González-López L; García-Iglesias T; Corona-Sánchez EG; Zavaleta-Muñiz S; Vargas-Ramírez R; Vázquez-Del Mercado M; Martín-Márquez BT
Scand J Rheumatol; 2012 Oct; 41(5):396-400. PubMed ID: 22639897
[TBL] [Abstract][Full Text] [Related]
14. Association of the ACTN3 R577X polymorphism with power athlete status in Russians.
Druzhevskaya AM; Ahmetov II; Astratenkova IV; Rogozkin VA
Eur J Appl Physiol; 2008 Aug; 103(6):631-4. PubMed ID: 18470530
[TBL] [Abstract][Full Text] [Related]
15. Altered Ca2+ kinetics associated with α-actinin-3 deficiency may explain positive selection for ACTN3 null allele in human evolution.
Head SI; Chan S; Houweling PJ; Quinlan KG; Murphy R; Wagner S; Friedrich O; North KN
PLoS Genet; 2015; 11(2):e1004862. PubMed ID: 25590636
[TBL] [Abstract][Full Text] [Related]
16. Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin.
Linde L; Boelz S; Nissim-Rafinia M; Oren YS; Wilschanski M; Yaacov Y; Virgilis D; Neu-Yilik G; Kulozik AE; Kerem E; Kerem B
J Clin Invest; 2007 Mar; 117(3):683-92. PubMed ID: 17290305
[TBL] [Abstract][Full Text] [Related]
17. The ACTN3 R577X genotype is associated with muscle function in a Japanese population.
Kikuchi N; Yoshida S; Min SK; Lee K; Sakamaki-Sunaga M; Okamoto T; Nakazato K
Appl Physiol Nutr Metab; 2015 Apr; 40(4):316-22. PubMed ID: 25761735
[TBL] [Abstract][Full Text] [Related]
18. The effect of α-actinin-3 deficiency on muscle aging.
Seto JT; Chan S; Turner N; MacArthur DG; Raftery JM; Berman YD; Quinlan KG; Cooney GJ; Head S; Yang N; North KN
Exp Gerontol; 2011 Apr; 46(4):292-302. PubMed ID: 21112313
[TBL] [Abstract][Full Text] [Related]
19. Association analysis of the ACTN3 R577X polymorphism and complex quantitative body composition and performance phenotypes in adolescent Greeks.
Moran CN; Yang N; Bailey ME; Tsiokanos A; Jamurtas A; MacArthur DG; North K; Pitsiladis YP; Wilson RH
Eur J Hum Genet; 2007 Jan; 15(1):88-93. PubMed ID: 17033684
[TBL] [Abstract][Full Text] [Related]
20. Nonsense-mediated mRNA decay and cystic fibrosis.
Linde L; Kerem B
Methods Mol Biol; 2011; 741():137-54. PubMed ID: 21594783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
